'Chemotherapy Induced Myelosuppression - Pipeline Review, H2 2013',
provides an overview of the indication's therapeutic pipeline. This
report provides information on the therapeutic development for
Chemotherapy Induced Myelosuppression, complete with latest updates, and
special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for
Chemotherapy Induced Myelosuppression.

Scope

- A snapshot of the global therapeutic scenario for Chemotherapy Induced
Myelosuppression.

- A review of the Chemotherapy Induced Myelosuppression products under
development by companies and universities/research institutes based on
information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging
from discover till registration stages.

- A feature on pipeline projects on the basis of monotherapy and
combined therapeutics.

- Coverage of the Chemotherapy Induced Myelosuppression pipeline on the
basis of route of administration and molecule type.

Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.